News & Statements
T1International Year in Review: 2019
19 Dec 2019, 10:01 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
We have had a truly incredible year. Unprecedented growth is the only way to put it. The global insulin crisis continues, but the momentum to counter this crisis is growing, thanks to patients around the world standing up and fighting for their right to health. Below, we share a summary of our highlights and biggest achievements, thanks to your donations, your advocacy, and your dedication to ensuring #insulin4all becomes a reality. Read more
Kentuckians Demand Legislation to Address Insulin Costs, Not Pharma-Funded Talking Points
2 Dec 2019, 9:28 a.m. in #insulin4all USA, News & Statements by Angela Lautner and Sarah Ferguson
Anything short of these 3 things mean that there will still be Kentuckians who suffer and possibly die. Money from the “big 3” insulin makers is influencing established advocacy groups across the United States, including some of the testimony heard at the August 21st ommittee meeting. When ideas are proposed that specifically remove blame and accountability from Pharma, it may be a key indicator of who is funding that group. Read more
#insulin4all Workshop & Vigil
25 Oct 2019, 10:09 a.m. in #insulin4all USA, News & Statements by T1International
In September 2019, T1International held our first ever two-day #insulin4all workshop for USA Chapters. The purpose of the workshop was to bring Chapter Leaders together and build their skills and advocating power to push for more affordable, accessible insulin and supplies. About 45 people from about 20 Chapters across the USA came to Indianapolis for the workshop, which included a third annual event outside of Eli Lilly taking the form of a vigil to honor lives lost due to rationing. Read more
Novo Nordisk Meeting: 2 Executives, 2 Doctors, 1 Patient
10 Jul 2019, 10:34 a.m. in #insulin4all USA, News & Statements by Karlynn Holland
Although Lars said that he is “Not shying away from anything that costs money,” it was clear that he was not going to lower the list price. I’m not holding my breath and we, the diabetes community, are not going to wait. Only legislation will ensure insulin is truly accessible and affordable for all. We will not stop until that is the reality because our lives depend on it. Read more
Colorado’s Insulin Copay Cap: A Foundation to Build Upon
9 Jul 2019, 9:13 a.m. in #insulin4all USA, News & Statements by Allison Bailey
With Governor Polis’ declaration that “the days of insulin price gouging are over in Colorado,” news outlets across the country published stories with headlines about the $100 price cap, patients lauded Colorado’s big step forward, and lawmakers from other states voiced interest in following suit. This bill was a victory for Colorado #insulin4all advocates. But with every victory, it is necessary to look beyond the headlines and explore the small print. Read more
T1International Releases Report on Rationing and Cost Survey Data
18 Jun 2019, 8 a.m. in #insulin4all USA, News & Statements by T1International
Results found that dangerous and potentially fatal insulin rationing is widespread globally, with 18.0% of all country respondents having rationed insulin at least once in the previous year. It also found that respondents from the USA paid more by the dollar for insulin than almost any other country and that 25.9% of U.S. respondents reported having rationed insulin in the previous year. This confirms similar findings from previous smaller-scale surveys that one of every four people in the United States have had to ration insulin. Read more
T1International at the Democratic Caucus Prescription Drug Prices Roundtable
13 Jun 2019, 4:14 p.m. in #insulin4all USA, News & Statements by Adeline (Lina) Umubyeyi
I appreciated the platform that myself and T1International were given to share our experiences and our clear requirements for any proposed solutions. I hope we will soon see a reduction in insulin costs to ensure it is truly affordable for everyone, and that is what we will continue to push for. Read more
T1International’s Advocates Plan Canada Trip to “Birthplace of Insulin”
12 Jun 2019, 8:52 a.m. in #insulin4all USA, News & Statements by T1International
On Friday, June 28, T1International #insulin4all advocates from the United States, in partnership with Health Care Voter, will join in a Caravan to Canada to purchase insulin at a significantly lower cost on the other side of the border. Advocates from T1International’s Minnesota #insulin4all Chapter will gather in Minneapolis, Minnesota and begin their journey. From there, the Chapter will travel to Lansing, Michigan to join the Michigan #insulin4all Chapter, with advocates from numerous other #insulin4all Chapters joining the caravan along the way. Read more
T1International at the UN UHC Multi-stakeholder Hearing
17 May 2019, 12:31 p.m. in Global Stories, News & Statements by Lauren Lehrer & Karlynn Holland
In particular, we call on pharmaceutical companies to show up with true solutions, not the same empty rhetoric. We are dying. There are solutions. It is times to protect rights of health and treatment for people living with diabetes and all those in desperate need of essential medicine – a vital part of health for all. Read more
T1International Statement on Lilly & Novo's ''Generic Insulin''
4 Mar 2019, 2:32 p.m. in #insulin4all USA, News & Statements by T1International
Patient-led activism is working. Today Eli Lilly announced that in response to criticism of high prices, the company will sell a version of Humalog insulin for half price. We are pleased to see this result after continual and dedicated efforts by non-pharma funded patient advocates to ensure list price of insulin goes down. While half-price is an improvement, it's still an unaffordable price for so many, considering most people need at least 2 vials each month.
Read more